Skip to main content
Admissions guidance, study banks, and career tools — get started on Shalyam
Research News

New Test Can Detect 'Broken Heart Syndrome' Like a Heart Attack

Mayur Tembhare
  1. Takotsubo syndrome affects mostly postmenopausal women and accounts for about 2% of patients initially thought to have a heart attack.

  2. The new BioTAK test uses blood biomarkers and sex to diagnose Takotsubo syndrome with high accuracy.

  3. The test correctly classified almost 90% of participants before they underwent cardiac catheterization.

  4. Takotsubo syndrome can be triggered by intense emotional or physical stress.

New Test Can Detect 'Broken Heart Syndrome' Like a Heart Attack

Topic: Health

Scientists have created a new test called BioTAK that can identify Takotsubo syndrome, also known as 'broken heart syndrome', with high accuracy. This condition mimics the symptoms of a heart attack but doesn't involve blocked coronary arteries. The test uses blood biomarkers and sex to diagnose the condition.

Takotsubo syndrome is a sudden heart condition that affects mostly postmenopausal women. It can be triggered by intense emotional or physical stress. This condition accounts for about 2% of patients initially thought to have a heart attack, but it's very hard to tell apart from a heart attack in the first stages of evaluation.

People with Takotsubo syndrome can experience chest pain, abnormal electrocardiogram results, and elevated levels of cardiac enzymes. These symptoms are similar to those of a heart attack. However, the key difference is that Takotsubo syndrome doesn't involve blocked coronary arteries.

A team of international researchers has developed a new diagnostic scoring system called BioTAK. This tool combines biological sex with several blood biomarkers linked to different processes in the cardiovascular system. The researchers used artificial intelligence to determine which combination of biomarkers provided the most useful diagnostic information and incorporated those markers into a clinical decision tool.

The BioTAK score was tested on nearly 1,800 patients and identified Takotsubo syndrome with high accuracy. The test correctly classified almost 90% of participants before they underwent cardiac catheterization.

Why It Matters

This new test can help doctors diagnose Takotsubo syndrome more accurately, reducing the number of unnecessary invasive tests. This is especially important in India, where heart disease is a growing concern. Early diagnosis and treatment can save lives and improve patient outcomes.

Key Facts

  • Takotsubo syndrome affects mostly postmenopausal women and accounts for about 2% of patients initially thought to have a heart attack.
  • The new BioTAK test uses blood biomarkers and sex to diagnose Takotsubo syndrome with high accuracy.
  • The test correctly classified almost 90% of participants before they underwent cardiac catheterization.
  • Takotsubo syndrome can be triggered by intense emotional or physical stress.
  • The condition doesn't involve blocked coronary arteries, unlike a heart attack.

Key Terms

Takotsubo syndrome
A sudden heart condition that mimics the symptoms of a heart attack but doesn't involve blocked coronary arteries.
BioTAK score
A diagnostic scoring system that combines biological sex with several blood biomarkers to diagnose Takotsubo syndrome.

Implications

This new test can help doctors diagnose Takotsubo syndrome more accurately, reducing the number of unnecessary invasive tests. This is especially important in India, where heart disease is a growing concern. Early diagnosis and treatment can save lives and improve patient outcomes.

Source: https://www.sciencedaily.com/releases/2026/09/260901070518.htm

Journal reference:

  1. Florian A Wenzl, Victor Schweiger, Maria A Smolle, Daniel Zech, Alexander Akhmedov, Peizhi Wang, Tetiana Lapikova-Bryhinska, Yujing Wang, Luca Liberale, Karine Santos, Yulia Ilina, Simon Kraler, Andreas Bergmann, Paul Kaufmann, Florian Kahles, Arnold von Eckardstein, Marco Roffi, Lorenz Räber, Victoria L Cammann, Jelena R Ghadri, Davide Di Vece, Thomas F Lüscher, Christian Templin. Takotsubo syndrome diagnosis: the biomarker-based BioTAK score. European Heart Journal, 2026; DOI: 10.1093/eurheartj/ehag597

Leave a comment

← All research

Get Exclusive Insights with Every Issue

Join Shalyam Newsletter

Stay ahead in education, research, and innovation—straight to your inbox.